Search Results for:
-
Jennerex Plucks $21.6M Private Placement; Is IPO Up Next?
The company said proceeds will be used for general corporate purposes, including clinical trial expenses and additional regulatory efforts related to erectile dysfunction drug Vitaros (alprostadil 0.3 percent topical cream) and female sexual dysfunction candidate Femprox (alprostadil 0.4 percent topical creamBy Marie Powers | BioWorld Today | Friday, May 24, 2013 -
Other News To Note
The clinical trial is anticipated to begin in late 2015BioWorld Today | Thursday, May 23, 2013 -
Pharma: Clinic Roundup
Results of the PROLASTIN-C SPARK study, a multidose pharmacokinetic clinical trial, were presented at the annual meeting of the American Thoracic Society in PhiladelphiaBioWorld Today | Thursday, May 23, 2013 -
Clinic Roundup
The study is being sponsored by the Alliance for Clinical Trials in Oncology, a cooperative group of the National Cancer Institute (NCIBioWorld Today | Thursday, May 23, 2013 -
AB Science's Masitinib Enters Phase III Trial for Alzheimer's
plc product bapineuzumab have dampened enthusiasm for Alzheimer's therapy and cast a shadow over subsequent late-stage clinical trials. (See BioWorld Today, Aug. 8, 2012, and Aug. 27, 2012.) Some firms have stumbled earlierBy Catherine Shaffer | BioWorld Today | Wednesday, May 22, 2013 -
Other News To Note
The program is expected to move into clinical trials within two yearsBioWorld Today | Wednesday, May 22, 2013 -
Financings Roundup
Funds will be used to support ongoing and new clinical trials and development and commercialization of Parkinson's psychosis drug pimavanserin and for general corporate purposes...Net proceeds are expected to total about $37.7 million and will be used to fund clinical trials of SFP, an iron compound for hemodialysis patients, and for general corporate purposesBioWorld Today | Wednesday, May 22, 2013 -
Other News To Note
The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), is being conducted at the NIAID Phase I Clinical Trials Unit at Case Western Reserve University in Cleveland...Proceeds would be used to fund clinical trials, R&D for additional alpha-1 antitrypsin (AAT) indications, expanding distribution capabilities for additional territories for marketing AAT product Glassia and for general corporate purposesBioWorld International | Wednesday, May 22, 2013 -
Clinic Roundup
Marina Biotech Inc., of Bothell, Wash., said licensee Mirna Therapeutics Inc., of Austin, Texas, has begun a Phase I study of MRX34, the first miRNA to advance into a human clinical trial for cancerBioWorld Today | Tuesday, May 21, 2013 -
Pharma: Clinic Roundup
The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), is being conducted at the NIAID Phase I Clinical Trials Unit at Case Western Reserve University in ClevelandBioWorld Today | Tuesday, May 21, 2013 -
Biotech Collaborations Between Pharmaceutical & Miscellaneous Companies: April 1 - May 16, 2013
clinical trial planning and execution of trials guided by Merck Serono's strategy The deal spans five years 5/16/13 NextBio (Santa Clara, Calif.) Sanofi SA (Paris) ND Multiyear collaboration aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi's drug R&D Terms were not disclosed 5/1/13 ScinoPharm Taiwan Ltd. (Tainan, Taiwan) Coland Holdings Ltd. (Hong Kong) ND Strategic alliance to develop a series of generic oncological drugs for mainland China ScinoPharmBioWorld Insight | Monday, May 20, 2013 -
Embryonic Stem Cells: Individual Medicine - But With 2 Individuals
Getting Fresh Eggs For non-patient specific stem cells currently in clinical trials, getting source cells is a one-time issue...Clinical trials involving personalized cellular therapies are closely supervised by the FDA, because while small-molecule drugs are static, destined to have a certain efficacy and safety profile, cellular therapies intrinsically vary between patients – and that variation is magnified by having not just a different patient each time, but a different egg donor for eachBy Anette Breindl | BioWorld Insight | Monday, May 20, 2013 -
Sepsis Patients May Need Bigger Immune Response
That realization – and the fact that dozens of drug hopefuls have failed in clinical trials – has prompted a search for new ways to fight sepsis. (See BioWorld Today, Jan. 3, 2012, Aug. 15, 2012, and Aug. 27, 2012.) Labeta and his team have turned their attention on the TLR system, but not in the typical way of targeting one class of TLRsBy Anette Breindl | BioWorld Today | Monday, May 20, 2013 -
Oncos Targets Solid Tumors With Oncolytic Virus Approach
Based on early findings, Oncos was launched in 2008 to take the technology into conventional clinical trials and seek a commercial path forwardBy Marie Powers | BioWorld Today | Monday, May 20, 2013 -
Clinic Roundup
ACT is currently enrolling patients in three clinical trials in the U.SBioWorld Today | Friday, May 17, 2013 -
Other News To Note
to produce and supply 123I-labeled NAV5001 for Navidea's late-phase clinical trials...The agreement focuses on Nordion's cGMP manufacturing and supply of NAV5001 clinical trial material to be produced at Nordion's Vancouver, British Columbia, facilityBioWorld Today | Friday, May 17, 2013 -
RuiYi, Genor Blaze Trail in China with JV for Rheumatoid Arthritis
TAIPEI, Taiwan – In what is likely one of the first attempts by a foreign biopharma to complete the full range of clinical trials in China for a new biologic, leading to regulatory and market approval by Chinese drug approval authorities, therapeutic antibodies specialist RuiYi Inc., of La Jolla, Calif., and Shanghai, entered a collaboration agreement with Genor BioPharma Co...RuiYi is leading the joint venture to take advantage of favorable conditions in China for clinical trials, for RABy Dave Silver | BioWorld Today | Friday, May 17, 2013 -
Ambit Cuts Price, Ups Shares; $65M IPO to Fund Quizartinib
Proceeds would be used to fund clinical trials, R&D for additional alpha-1 antitrypsin (AAT) indications, expanding distribution capabilities for additional territoriesBy Jennifer Boggs | BioWorld Today | Friday, May 17, 2013 -
Pharma: Other News To Note
Approval was supported by data from the Program of Ulcerative Colitis Research Studies Utilizing an Investigational Treatment (PURSUIT) clinical trials, evaluating patients with moderately to severely active UC who had previously failed or were intolerant to conventional treatmentsBioWorld Today | Friday, May 17, 2013 -
Pharma: Other News To Note
Under the agreement, Quintiles will direct clinical trial planning and execution of trials guided by Merck Serono's strategyBioWorld Today | Thursday, May 16, 2013
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9744)
- x BioWorld International (1951)
- x BioWorld Insight (1198)
- x Bio Perspectives (295)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.